Wei An is an Associate Director and Biomarker Clinical Assay Lead at Pfizer, where they currently develop clinical assays. Previously, between 2020 and 2022, they held positions at BioLegend, notably as Manager of Diagnostic Flow Product Development, overseeing FDA-regulated flow cytometry products. Prior to that, Wei worked at the University of Nebraska Medical Center as a Research Instructor and Research Associate, focusing on cancer immunotherapy and leukemia biomarker development. Wei earned a Ph.D. in Genetics and Cell Biology from the University of Nebraska Medical Center from 2010 to 2015.
This person is not in the org chart
This person is not in any teams
This person is not in any offices